US OptionsDetailed Quotes
RIGL241220C15000
- 4.50
- 0.000.00%
15min DelayClose Dec 12 13:34 ET
0.00High0.00Low
0.00Open4.50Pre Close0 Volume86 Open Interest15.00Strike Price0.00Turnover298.50%IV2.15%PremiumDec 20, 2024Expiry Date4.09Intrinsic Value100Multiplier4DDays to Expiry0.41Extrinsic Value100Contract SizeAmericanOptions Type0.8258Delta0.0430Gamma3.98Leverage Ratio-0.1982Theta0.0012Rho3.28Eff Leverage0.0052Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet